CCClarity Pharmaceuticals Ltd.
2.71USDD
−0.13−4.75%
At close at Jul 25, 19:05 GMT
USD
No trades
Price target
4.81DUSD+2.10+77.81%
The 5 analysts offering 1 year price forecasts for Clarity Pharmaceuticals Ltd. have a max estimate of 5.94 and a min estimate of 3.30.
Analyst rating
Based on 5 analysts giving stock ratings to Clarity Pharmaceuticals Ltd. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
3
Buy
2
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
H2 '25
H1 '26
H2 '26
H1 '27
−0.06
−0.04
−0.03
−0.01
0.00
Reported
Estimate
Currency: USD
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
H2 '25
H1 '26
H2 '26
H1 '27
Reported
−0.03
−0.04
−0.04
−0.05
—
—
—
—
Estimate
−0.03
−0.04
−0.03
−0.05
−0.04
−0.05
−0.06
−0.06
Surprise
−24.48%
−16.10%
−14.48%
−0.68%
—
—
—
—
Revenue
Forecast
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
H2 '25
H1 '26
H2 '26
H1 '27
0.00
2.10 M
4.20 M
6.30 M
8.40 M
Reported
Estimate
Currency: USD
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
H2 '25
H1 '26
H2 '26
H1 '27
Reported
0.00
0.00
4.06 M
0.00
—
—
—
—
Estimate
1.34 M
0.00
3.29 M
3.66 M
7.26 M
5.13 M
6.27 M
8.25 M
Surprise
−100.00%
—
+23.51%
−100.00%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CLRPF EPS for the last quarter is −0.05 USD despite the estimation of −0.05 USD. In the next quarter EPS is expected to reach −0.04 USD. Track more of Clarity Pharmaceuticals Ltd. financials and stay on top of what is up with the company.
In the next quarter Clarity Pharmaceuticals Ltd. revenue is expected to reach 7.26 M USD. Check out Clarity Pharmaceuticals Ltd. revenue and earnings and make informed decisions.
According to analysts, CLRPF price target is 4.81 USD with a max estimate of 5.94 USD and a min estimate of 3.30 USD. Check if this forecast comes true in a year, meanwhile watch Clarity Pharmaceuticals Ltd. stock price chart and keep track of the current situation with CLRPF news and stock market news.
We've gathered opinions of 5 analysts rating CLRPF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.